In vivoAdministration of Intravenous Immunoglobulin (IVIg) can Lead to Enhanced Erythrocyte Sequestration
- 1 August 1999
- journal article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 13 (1), 129-135
- https://doi.org/10.1006/jaut.1999.0302
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Exposure to complement-bearing immune complexes enhances the in vitro sequestration of erythrocytes from young but not elderly donorsClinical and Experimental Immunology, 2008
- Immune complex-like moieties in immunoglobulin for intravenous use (IVIg) bind complement and enhance phagocytosis of human erythrocytesClinical and Experimental Immunology, 1998
- New therapeutic avenues in autoimmunityResearch in Immunology, 1996
- Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitroClinical and Experimental Immunology, 1994
- Hemolysis after high-dose intravenous Ig [letter]Blood, 1993
- Initial stabilization preceding enhanced hemolysis in autoimmune hemolytic anemia treated with intravenous gammaglobulinThe Journal of Pediatrics, 1987
- Release of Immune Complexes bound to Erythrocyte Complement Receptor (CR1), with Particular Reference to the Role of Factor IScandinavian Journal of Immunology, 1986
- High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome)The Journal of Pediatrics, 1985
- Lack of efficacy of high‐dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism*Scandinavian Journal of Haematology, 1985
- EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA: Competitive Inhibition of Reticuloendothelial System Function by Sequestration of Autologous Red Blood Cells?The Lancet, 1983